Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification

Identification of molecular phenotypes in canine mammary carcinomas with clinical implications:... Similarly to humans, canine mammary cancer represents a heterogeneous group in terms of morphology and biological behaviour. In the present study, we evaluated a series of canine mammary carcinomas based on a new human classification, initially based on gene expression profiling analysis. Similarly to human breast cancer, by using an immunohistochemistry surrogate panel based on five molecular markers [estrogen receptor, human epidermal growth factor receptor 2 (HER2), cytokeratin 5, p63 and P-cadherin], we were able to classify canine mammary carcinomas into four different subtypes: luminal A [estrogen receptor (ER)+/HER2−; 44.8%], luminal B (ER+/HER2+; 13.5%), basal (ER−/HER2− and a basal marker positive; 29.2%) and HER2 overexpressing tumours (ER−/HER2+; 8.3%). Luminal A-type tumours were characterised by lower grade and proliferation rate, whereas basal-type tumours were mostly high grade, high proliferative and positive for cytokeratin 5, p63 and P-cadherin. In addition, as in humans, basal subtype was significantly associated with shorter disease-free and overall survival rates, and we propose canine mammary carcinomas as a suitable natural model for the study of this particular subset of human carcinomas. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Virchows Archiv Springer Journals

Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification

Virchows Archiv , Volume 453 (2) – Aug 2, 2008

Loading next page...
 
/lp/springer-journals/identification-of-molecular-phenotypes-in-canine-mammary-carcinomas-dx3PwDbjq0

References (62)

Publisher
Springer Journals
Copyright
Copyright © 2008 by Springer-Verlag
Subject
Medicine & Public Health; Pathology
ISSN
0945-6317
eISSN
1432-2307
DOI
10.1007/s00428-008-0644-3
pmid
18677512
Publisher site
See Article on Publisher Site

Abstract

Similarly to humans, canine mammary cancer represents a heterogeneous group in terms of morphology and biological behaviour. In the present study, we evaluated a series of canine mammary carcinomas based on a new human classification, initially based on gene expression profiling analysis. Similarly to human breast cancer, by using an immunohistochemistry surrogate panel based on five molecular markers [estrogen receptor, human epidermal growth factor receptor 2 (HER2), cytokeratin 5, p63 and P-cadherin], we were able to classify canine mammary carcinomas into four different subtypes: luminal A [estrogen receptor (ER)+/HER2−; 44.8%], luminal B (ER+/HER2+; 13.5%), basal (ER−/HER2− and a basal marker positive; 29.2%) and HER2 overexpressing tumours (ER−/HER2+; 8.3%). Luminal A-type tumours were characterised by lower grade and proliferation rate, whereas basal-type tumours were mostly high grade, high proliferative and positive for cytokeratin 5, p63 and P-cadherin. In addition, as in humans, basal subtype was significantly associated with shorter disease-free and overall survival rates, and we propose canine mammary carcinomas as a suitable natural model for the study of this particular subset of human carcinomas.

Journal

Virchows ArchivSpringer Journals

Published: Aug 2, 2008

There are no references for this article.